Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does VORTIOXETINE HYDROBROMIDE Cause Drug screen false positive? 18 Reports in FDA Database

Sharpen Your Memory & Focus Naturally

NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.

Boost Your Brain

According to the FDA Adverse Event Reporting System (FAERS), 18 reports of Drug screen false positive have been filed in association with VORTIOXETINE HYDROBROMIDE (Trintellix). This represents 0.1% of all adverse event reports for VORTIOXETINE HYDROBROMIDE.

18
Reports of Drug screen false positive with VORTIOXETINE HYDROBROMIDE
0.1%
of all VORTIOXETINE HYDROBROMIDE reports
0
Deaths
2
Hospitalizations

How Dangerous Is Drug screen false positive From VORTIOXETINE HYDROBROMIDE?

Of the 18 reports, 2 (11.1%) required hospitalization.

Is Drug screen false positive Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for VORTIOXETINE HYDROBROMIDE. However, 18 reports have been filed with the FAERS database.

What Other Side Effects Does VORTIOXETINE HYDROBROMIDE Cause?

Nausea (2,062) Anxiety (861) Vomiting (811) Suicidal ideation (742) Headache (738) Fatigue (697) Drug ineffective (693) Pruritus (653) Insomnia (636) Feeling abnormal (620)

What Other Drugs Cause Drug screen false positive?

RANITIDINE (104) NALTREXONE (91) BUPROPION (63) SERTRALINE (58) VENLAFAXINE (50) LAMOTRIGINE (48) PANTOPRAZOLE (44) QUETIAPINE (44) IBUPROFEN (37) PREGABALIN (37)

Which VORTIOXETINE HYDROBROMIDE Alternatives Have Lower Drug screen false positive Risk?

VORTIOXETINE HYDROBROMIDE vs VOSORITIDE VORTIOXETINE HYDROBROMIDE vs VOTRIENT VORTIOXETINE HYDROBROMIDE vs VOXELOTOR VORTIOXETINE HYDROBROMIDE vs VUTRISIRAN VORTIOXETINE HYDROBROMIDE vs VX-950

Related Pages

VORTIOXETINE HYDROBROMIDE Full Profile All Drug screen false positive Reports All Drugs Causing Drug screen false positive VORTIOXETINE HYDROBROMIDE Demographics